Cardiovascular Systems, Inc. Announces First Peripheral Arterial Disease Case Treated With New, Low-Profile, 60cm Diamondback Peripheral System

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), today announced the first use of its Diamondback 360® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD). Jihad A. Mustapha, M.D., FACC, FSCAI, Director of Heart and Vascular at Metro Health Hospital in Wyoming, Mich., performed the procedure through Tibiopedal access using the new, low-profile device.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC